MedPath

The comparison of effectiveness between intravenous and subcutaneous administration route of tocilizumab in patients with rheumatoid arthritis

Not Applicable
Recruiting
Conditions
rheumatoid arthritis
Registration Number
JPRN-UMIN000028261
Lead Sponsor
Osaka City University Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with other diseases that can affect the infllamation state. Patients who was deemed inappropriate by test doctor to participate in this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The comparison of ultrasonographic findings between intravenus and subcutaneous administration route of tocilizumab
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath